In a survey of 2,000 U.S. consumers, 1,500 reported using a CBD product within the last three months. The demand for CBD in multiple types of consumer goods—from foods to healthcare to beauty products—is creating an explosion of brands hitting the market.
Cannabidiol (CBD) has been the focus of many medical cannabis studies, and continues to prove itself as a powerful anti-inflammatory drug. What makes CBD even more desirable for some patients is that it does not cause the psychoactive effects associated with tetrahydrocannabinol (THC).
Cannabidiol (CBD) is an exciting focus of medical research, popular media, and legislation related to cannabis. Its presence is becoming ubiquitous on the shelves of health food stores and search engine results for numerous medical conditions, but don’t believe everything you hear. While CBD is an incredibly safe and therapeutic component of cannabis, there are many myths and misconceptions associated with it. Let’s take a look at a few.
Vancouver resident Carol Francey, 70, attributed cannabis use of more than five decades to her excellent health today. According to Francey, she smoked cannabis to alleviate various conditions such as arthritis, sciatica, and insomnia. Francey added that her previous medications used to affect her balance and slurred her speech. However, the use of various forms of cannabis proved helpful in relieving her conditions without the unwanted side effects from her medications.
A recent study conducted by a pair of researchers from South Africa identifies cannabidiol (CBD) as potentially beneficial for treating cervical cancer.
One of the effects of chronic cannabinoid use could be a more subdued response when faced with stressful situations, according to a new study published Psychopharmacology. Scientists from Washington State University found that when placed in a simulated stressful situation, those who regularly consume cannabinoids produce less cortisol, the body’s main stress hormone.
When it comes to treating mental illnesses – especially depression – the options are unfortunately extremely limited. Most of the time pharmaceutical drugs can take weeks, if not months, before the patient notices a difference and oftentimes antidepressant medications are extremely addictive with a long list of potential side effects if you quit taking them suddenly. The worst part is that antidepressants only work for some people – at least 1 in 3 people with depression are unable to find relief through current antidepressant drugs.
There have been some confusing reports recently in the British media about a compound in cannabis called CBD and how it has been reclassified as medicine.
Last week saw the announcement that THCa, another molecule found in the cannabis plant, has neuroprotective effects. Apart from flying in the face of the belief that cannabis damages brain cells, why should we care whether something is neuroprotective or not?
When talking about the therapeutic effects of CBD, it’s often the cannabinoid’s pain reducing ability that is mentioned. As headaches are the most common source of pain in the general population, it would make sense then that CBD could be an interesting therapeutic target.
A patient testimonial from a 72-year-old Oregon resident who has been weaning herself off opioids with the help of CBD-rich cannabis.
A new research review investigating CBD’s potential therapeutic properties for Alzheimer’s disease suggests the compound could be beneficial for treating the neurodegenerative disease.
The introduction of cannabidiol (CBD), a non-psychoactive cannabis compound known for its ability to reduce chronic inflammation, alleviate seizures and increase energy, to the medical community has catapulted the reputation and applications of hemp oil for patients seeking natural forms of treatment.
